BIOL earnings

DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies."During the second quarter we advanced capital to two existing borrowers and are working towards an additional closing in the next month," said SWK President and CEO Jody Staggs."Importantly, several of our borrower partners took advantage of the strong capital markets to raise equity or other forms of non-dilutive financing. We also repurchased $1 million of st

Increased Adoption of Dental Lasers and Improved Cost Structure Position Company for Sustained Long Term Growth and SuccessLAKE FOREST, CA / ACCESSWIRE / May 13, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported its financial results for the first quarter ended March 31, 2024.First Quarter Financial HighlightsGenerated increased adoption of its industry-leading laser, with approximately 67% of U.S. Waterlase sales coming from new customers and approximately 42% from dental specialistsThird strongest consumable sales quarter in company history, with consumable sales increasing 14% year over year, largely driven by over 600 subscriptionsGross margin was re

LAKE FOREST, CA / ACCESSWIRE / May 6, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release first quarter 2024 financial and operating results on Monday, May 13, 2024, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.To access the live call, dial 877-270-2148 (U.S.) or +1 412-902-6510 (International) and ask to join the BIOLASE call.A live and archived conference call webcast will be accessible on the BIOLASE Investor Relations Page. In addition, a phone replay will be available approxi

LAKE FOREST, CA / ACCESSWIRE / March 14, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release fourth quarter and full year 2023 financial and operating results on Thursday, March 21, 2024, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.To access the live call, dial 877-270-2148 (U.S.) or +1 412-902-6510 (International) and ask to join the BIOLASE call.A live and archived conference call webcast will be accessible on the BIOLASE Investor Relations Page. In addition, a phone replay wil

LAKE FOREST, Calif., Aug. 2, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. To access the live call, dial 888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following access code: 679201. A live and archived webcast of the c

Educational and Training Programs Introducing Broader Community of Dentists to Experience Industry-Leading Dental Lasers for the First Time LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023. First Quarter Financial Highlights Reported revenue of $10.5 million, the ninth consecutive quarter of year-over-year growthIncreased international laser sales by 22% year over yearRecord quarter in consumable sales, with U.S. consumable sales i

LAKE FOREST, Calif., May 4, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. To access the live call, dial 877-545-0523 (U.S.) or +1 973-528-0016 (International) and provide the following access code: 180082. A live and archived webcast of the confer

LAKE FOREST, Calif., March 28, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2022. 2022 Full-Year Financial Highlights Achieved year-over-year revenue growth of 24% to $48.5 millionIncreased U.S. laser sales by 39% year over yearAchieved record U.S. consumable sales, up 25% year over year, driven by increased procedures using BIOLASE lasersGenerated increased adoption of its industry-leading laser, with approximately 84% of U.S. Waterlase sales

LAKE FOREST, Calif., March 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full year 2022 financial and operating results on Tuesday, March 28, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. To access the live call, dial 888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following earnings code: 121864. A live and archived

LAKE FOREST, Calif., Nov. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2022. 2022 Third Quarter Highlights Total revenue was $12.0 million, up 26% year over yearU.S. laser sales increased 35% year over year and U.S. consumable sales increased 22% year over year, driven by increased procedures using BIOLASE lasersContinued momentum with new customers and dental specialists with over 90% of U.S. Waterlase sales coming from new customers and approximately 4

LAKE FOREST, Calif., Oct. 27, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. To access the live call, dial 888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following earnings code: 720380. A live and archived webcast of th

LAKE FOREST, Calif., Aug. 11, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2022. 2022 Second Quarter and Recent Highlights Total revenue was $12.2 million, up 34% year over yearU.S. laser sales increased 70% year over year and U.S. consumable sales increased 42% year over year, driven by increased procedures using BIOLASE lasersInternational laser sales increased 2% year over year, while international consumable sales increased 3% year over yearContinued momentu

LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. To access the live call, dial 877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following earnings code: 838343. A live and archived webcast of the

LAKE FOREST, Calif., May 12, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2022. 2022 First Quarter and Recent Highlights Total revenue was $10.2 million, up 25% year over yearU.S. laser sales increased 43% year over year and U.S. consumable sales increased 35% year over year, driven by increased procedures using BIOLASE lasersInternational laser sales increased 15% year over year, while international consumable sales remained consistentHigher average selling pri

FOOTHILL RANCH, Calif., May 4, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release first quarter 2022 financial and operating results on Thursday, May 12, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. To access the live call, dial 1-877-317-6789 (U.S.) or +1 412-317-6789 (International) and ask to join the BIOLASE earnings call. A live and archived webcast of the confer

Robust Balance Sheet to Execute Growth Strategies in 2022 Full Year 2022 Revenue Growth Outlook +10% LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2021. 2021 Fourth Quarter and Recent Highlights Total revenue was 12.4 million, up 46% year over year Total revenue also increased 22% over fourth quarter 2019 pre-COVID results U.S. laser sales increased 39% year over year and U.S. consumable sales increased 40% year o

FOOTHILL RANCH, Calif., March 3, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2021 financial and operating results on Thursday, March 17, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in t

FOOTHILL RANCH, Calif., Nov. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for its third quarter ended September 30, 2021 and provided fourth quarter 2021 revenue guidance. 2021 Third Quarter Operating Highlights (all comparisons are on a year-over-year basis unless specified otherwise): Net revenue grew 46% to $9.5 million: 78% of U.S. laser sales came from new customers, continuing a positive trend Approximately 35% of U.S. Waterlase sales came from dental specialists Net revenue was 10% higher

FOOTHILL RANCH, Calif., Nov. 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release third quarter 2021 financial and operating results on Wednesday, November 10, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Cana

FOOTHILL RANCH, Calif., Aug. 12, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for its second quarter ended June 30, 2021 and provided third quarter 2021 revenue guidance. 2021 Second Quarter Operating Highlights (all comparisons are on a year-over-year basis unless specified otherwise): Net revenue grew 211% to $9.1 million: Over 70% of U.S. laser sales came from new customers, continuing a positive trend Over 35% of U.S. Waterlase sales came from dental specialists Net revenue was 6% higher than th

FOOTHILL RANCH, Calif., Aug. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it will release second quarter 2021 financial and operating results on Thursday, August 12, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada

FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021. 2021 First Quarter Operating Highlights (all comparisons are on a year over year basis): Net revenue grew 70% to $8.1 million with: 79% of sales from new users, continuing a positive trend 36% of sales from dental specialistsLaser system sales increased 139% Consumables and other revenue increased 52% U.S. revenue increased 67% International revenue increased 75% Gross margin was

FOOTHILL RANCH, Calif., March 25, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2020. 2020 Fourth Quarter Operating Highlights and Recent Developments: Total revenue was $8.5 million, representing sequential quarterly growth of 31%. U.S. revenue exceeded the prior-year fourth quarter, despite COVID-19 headwinds. 78% of sales came from new users, continuing a positive trend. 40% of sales came from dental specialists, a significant increase compared to recent prior periods. Several Dental Services Organizations ("DSOs") purchased BIOLASE products in the fo